Pay in 4 interest-free payments of $5.07 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Individual responses may vary with continued use over time
Munoz-Fernandez MA, Pimentel-Muinos FX, Alonso MA, Campanero M, Sanchez-Madrid F, Silva A, et al
245 At the time of writing, the SURMOUNT-MMO trial is currently underway to investigate the cardiovascular outcomes of tirzepatide in people with overweight/obesity without type 2 diabetes
A patient who can afford consistent, long-term GLP-1 therapy is more likely to remain engaged with their treatment plan, maintain appropriate dosing schedules, and report side effects to their provider
For a 100kg individual, that translates to 22.5kg lost versus 2.4kg
Some individuals notice increased fatigue, muscle tightness, or reduced recovery when intake becomes lower over time
US$ 24.28
US$ 26.86
US$ 22.19
